Top Markets
Coin of the day
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Rank in Stocks #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Share Price
$12.94
Last synced: 2026-08-28
Market Cap
$1.10B
Change (1 day)
-0.16%
Change (1 year)
-51.50%
Country
US
Trade Kolon TissueGene, Inc. (950160)

Category

Price of 950160 with the market cap of B
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
950160
$12.94
Market Capitalization of Kolon TissueGene, Inc.(950160)
Market Cap: $1.10B
As of August 2026 Kolon TissueGene, Inc. has a market cap of $1.10B. This makes Kolon TissueGene, Inc. the world's 9085th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Kolon TissueGene, Inc. from 2017 to 2026
950160 compared with Top 5 Most Popular stocks
Price of 950160 Asset B Mkt. of B Results
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
$62,120.76 $1.10B
$5.264T +480,047.64%
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
$55,481.41 $1.10B
$4.701T +428,730.41%
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
$49,296.35 $1.10B
$4.177T +380,924.40%
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
$45,050.50 $1.10B
$3.817T +348,107.10%
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
$33,826.65 $1.10B
$2.866T +261,355.06%